Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromodomain containing 7 pseudogene 6 (BRD7P6) is a processed, non-protein-coding pseudogene in the human genome. Pseudogenes are generally nonfunctional in protein coding, but some may regulate their parent or related coding genes at the RNA level. For BRD7P6 specifically, no evidence currently exists that it encodes a protein, functions as a biomarker, or is a therapeutic or druggable target. Its parent gene, BRD7, encodes a bromodomain-containing protein involved in chromatin remodeling and tumor suppression, but these attributes do not apply to BRD7P6[2][4][5][7]. All mechanistic, therapeutic, and disease associations in BRD7 research refer to the *BRD7 protein*, not to BRD7P6. Any confusion likely results from misidentification[2][4][5]. No structured biomedical information exists for BRD7P6 as a functional target—it is catalogued as a pseudogene in authoritative databases[3][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain containing 7 pseudogene 6 (BRD7P6).